Concepedia

Bahram Forouzesh

BF

Statistics

Publications

10

Citations

704

H-Index

10

Active since

2001

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Brooke Army Medical Center

PharmaMar (Spain)

Bahram Forouzesh is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, cancer pharmacology, and toxicity management.

ORCID

Publications per year

2001–2010

10

Publications

10

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

Alain C. Mita, Louis Denis, Eric K. Rowinsky et al. · Clinical Cancer Research · 2009 · 332 citations

, , +16

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Eric K. Rowinsky, Jinee Rizzo, Leonel Ochoa et al. · Journal of Clinical Oncology · 2002 · 132 citations

, , +17

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

Quincy Chu, Bahram Forouzesh, Samira Syed et al. · Investigational New Drugs · 2007 · 61 citations

, , +14

Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer

Chris H. Takimoto, Lisa A. Hammond-Thelin, Jane E. Latz et al. · Clinical Cancer Research · 2007 · 47 citations

, , +15

Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer

Jan C. Buckner, Bahram Forouzesh, Charles Erlichman et al. · Investigational New Drugs · 2009 · 45 citations

, , +14

1–5 of 10